The annual report on the diagnosis, management, and prevention of COPD has been published by GOLD

AdobeStock_282270715 (1)

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the GOLD 2022 report, entitled Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD). 

The GOLD 2022 report is a revision of the 2021 report, and includes new and updated recommendations on the diagnosis, management, and prevention of COPD, according to recent evidence from the literature.

Key updates in the 2022 report include new definitions for early COPD, mild COPD, COPD in young people, and pre-COPD, and new recommendations on the use of diffusing capacity of the lungs for carbon monoxide measurement for COPD assessment.

Information on the pharmacological treatment of COPD has been amended in the updated report, and a new section has been added on the effectiveness of tele-rehabilitation, which has been proposed as an alternative to the traditional approaches of pulmonary rehabilitation in COPD.


In the 2021 update, a new chapter was added on COPD in the context of COVID-19. This has been updated in the 2022 report, with updated recommendations on the risks associated with COVID-19, and new advice on COVID-19 vaccination for patients with COPD. GOLD discusses the effectiveness of COVID-19 vaccines against SARS-CoV-2 infection requiring hospitalisation, ICU admission, or emergency care, including in those with chronic respiratory disease, and advises that patients with COPD should receive COVID-19 vaccination in line with national recommendations.

Chapters within the 2021 report include:

  • definition and overview
  • diagnosis and initial assessment
  • evidence supporting prevention and maintenance therapy
  • management of stable COPD
  • COPD and comorbidities
  • COVID-19 and COPD.


Lead image: SciePro/

Image 1: SciePro/